We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGA
5126
DELISTED
Transglobe Energy Corp
TGA
$2K ﹤0.01%
922
-1,546
-63% -$2.64K
FST
5127
DELISTED
FAST Acquisition Corp.
FST
$2K ﹤0.01%
+136
New +$1.68K
BKEP
5128
DELISTED
Blueknight Energy Partners L.P.
BKEP
$2K ﹤0.01%
+419
New +$1.5K
GSV
5129
DELISTED
Gold Standard Ventures Corp.
GSV
$2K ﹤0.01%
4,300
+2,920
+212% +$1.72K
DSAC
5130
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$2K ﹤0.01%
197
-23
-10% -$225
GGPIU
5131
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
$2K ﹤0.01%
+190
New +$1.9K
EJFAU
5132
DELISTED
EJF Acquisition Corp. Unit
EJFAU
$2K ﹤0.01%
154
APSG.U
5133
DELISTED
Apollo Strategic Growth Capital Units, each consisting of one Class A Ordinary Share and one-third W
APSG.U
$2K ﹤0.01%
168
-412
-71% -$4.21K
SVSVU
5134
DELISTED
Spring Valley Acquisition Corp. Unit
SVSVU
$2K ﹤0.01%
+193
New +$2.02K
DISCB
5135
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$2K ﹤0.01%
39
-1
-3% -$75
SPAQ
5136
DELISTED
Spartan Acquisition Corp. III
SPAQ
$2K ﹤0.01%
+225
New +$2.21K
BTAQ
5137
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$2K ﹤0.01%
+253
New +$2.51K
ADXS
5138
DELISTED
Advaxis Inc
ADXS
$2K ﹤0.01%
4,069
-40,289
-91% -$20.4K
HCAQ
5139
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2K ﹤0.01%
232
+100
+76% +$989
BSN.U
5140
DELISTED
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
$2K ﹤0.01%
150
+100
+200% +$1.03K
BSCL
5141
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$2K ﹤0.01%
100
-300
-75% -$6.33K
YAC.U
5142
DELISTED
Yucaipa Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
YAC.U
$2K ﹤0.01%
200
+100
+100% +$1.02K
CBAH.U
5143
DELISTED
CBRE Acquisition Holdings, Inc. SAIL securities, each consisting of one share of Class A common stoc
CBAH.U
$2K ﹤0.01%
156
-344
-69% -$3.47K
DCRCU
5144
DELISTED
Decarbonization Plus Acquisition Corporation III Unit
DCRCU
$2K ﹤0.01%
180
-220
-55% -$2.3K
DDMXU
5145
DELISTED
DD3 Acquisition Corp. II Unit
DDMXU
$2K ﹤0.01%
+156
New +$1.63K
MOTNU
5146
DELISTED
Motion Acquisition Corp. Unit
MOTNU
$2K ﹤0.01%
200
-54
-21% -$554
CLDB
5147
DELISTED
CORTLAND BNCP CRTLD OHIO
CLDB
$2K ﹤0.01%
58
-813
-93% -$19.7K
MCADU
5148
DELISTED
Mountain Crest Acquisition Corp. II Unit
MCADU
$2K ﹤0.01%
197
LATNU
5149
DELISTED
Union Acquisition Corp. II Units containing one ordinary share and one redeemable warrant
LATNU
$2K ﹤0.01%
+228
New +$2.46K
PACE.U
5150
DELISTED
TPG Pace Tech Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fifth
PACE.U
$2K ﹤0.01%
200

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.